SEC Company Response from Newborn Acquisition Corp (CIK 0001780262) — Feb 12, 2020
Newborn Acquisition Corp (CIK 0001780262)
Date: Feb. 12, 2020 · CIK: 0001780262 · Accession: 0001213900-20-003335
AI Filing Summary & Sentiment
File numbers found in text: 333-235788
Referenced dates: February 11, 2020
Show Raw Text
CORRESP
1
filename1.htm
Giovanni Caruso
Partner
345 Park Avenue
New York, NY 10154
Direct 212.407.4866
Main 212.407.4000
Fax 212.937.3943
gcaruso@loeb.com
Via Edgar
February 12, 2020
Ms. Susan Block
Division of Corporation Finance
Office of Real Estate & Construction
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re: Newborn Acquisition Corp.
Amendment No. 1 to
Draft Registration Statement on Form S-1
Filed February 4, 2020
File No. 333-235788
Dear Ms. Block:
On behalf of our client, Newborn Acquisition
Corp. (the “Company”), we hereby provide a response to the comments issued in a letter dated February 11, 2020 (the
“Staff’s Letter”) regarding the Company’s Amendment No. 1 to draft Registration Statement on Form S-1 (the
“Registration Statement”). Contemporaneously, we are submitting the amended draft Registration Statement via Edgar
(the “Amended S-1”).
In order to facilitate the review by
the Commission’s staff (the “Staff”) of the Amended S-1, we have responded, on behalf of the Company, to the
comments set forth in the Staff’s Letter on a point-by-point basis. The numbered paragraphs set forth below respond to the
Staff’s comments and correspond to the numbered paragraph in the Staff’s Letter.
Los
Angeles New York Chicago Nashville
Washington, DC Beijing Hong Kong www.loeb.com
A limited
liability partnership including professional corporations
Susan Block
February 12, 2020
Page 2
Amended Form S-1 filed February
4, 2020
Use of proceeds, page 40
1. Please revise to clarify your statement on page 41 that "all public
shareholders who vote against the amendment of [the investment management trust agreement] will be granted the right to convert
their ordinary shares into their pro rata share of the aggregate amount then on deposit in the trust account" in light of
your statement on page 27 that you "will offer each public shareholder the option to vote in favor of a proposed [amendment
to the investment management trust agreement], and still seek conversion of his, her or its public shares."
Response: The disclosure
on pages 27 and 41 has been revised to clarify that a public stockholder can elect to convert its shares regardless of whether
the stockholder votes for or against the amendment or business combination.
Exhibits 4.5 and 4.6, page
II-2
2. We note that the Warrant Agreement filed as Exhibit 4.5 and the Rights
Agreement filed as Exhibit 4.6 provide that the Company and Warrant Agent and the Company, respectively, agree that any action,
proceeding or claim against it arising out of or relating in any way to the agreement shall be brought and enforced in the courts
of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to
such jurisdiction, "which jurisdiction shall be exclusive." If these provisions require investors in this offering to
bring any such action, proceeding or claim in the courts of the State of New York or the United States District Court for the Southern
District of New York, please disclose such provision in your registration statement, and disclose whether the provision applies
to actions arising under the Securities Act or Exchange Act. If the provisions are not intended to bind investors in this offering
please revise the agreements to so clarify. If the provisions apply to actions arising under the Securities Act or Exchange Act,
please also add related risk factor disclosure. If the provisions do not apply to actions arising under the Securities Act or Exchange
Act, please also ensure that the above agreements state this clearly.
Response: The Warrant Agreement
and Rights Agreement has each been revised to clarify that the indicated provision does not apply to holders of warrants or rights,
as applicable, and does not apply to claims under the Securities Act or Exchange Act.
Please call me at 212 407-4866
if you would like additional information with respect to any of the foregoing. Thank you.
Sincerely,
/s/ Giovanni Caruso
Giovanni Caruso
Partner